Dr. Yang is Chair Professor of National Taiwan University College of Medicine. He was the former President of National Taiwan University. His major research interests are lung cancer genomics and precision lung cancer therapy. He was elected as member of Academia Sinica in 2006, the World Academic of Science in 2008, the National Academy of Inventors of USA in 2015 and the International Association for the Study of Lung Cancer (IASLC) the 2020Joseph W. Cullen Prevention/Early Detection Distinguished Service Award because of his contributions in leading the translational research in precision cancer medicine and the implementation of lung cancer screening in never smoker, which significantly improved the survival of lung cancer patients in Taiwan. Their research group identified the proteogenomics signatures of pathogenesis and progression of never smoker lung cancer in East Asian population. They successfully established new platforms of theranostic applications of aptamer and smart targeting of cancer stem cell and tumor microenvironment that may provide new strategy to improve treatment outcome of lung cancer patients.

Pedro Nazareht Aguiar Junior MD, MSc, PhD, MBA
Grupo Oncoclínicas, São Paulo, Brazil
Faculdade de Medicina do ABC, Santo André, Brazil
Pharmacoeconomics Reseacher
Experience in the field of Clinical Oncology Protocols, Reimbursement Models and Value Based Medicine

Dr. Schabath is an Associate Member (tenured) at the Moffitt Cancer Center with joint appointments in the Departments of Cancer Epidemiology and Thoracic Oncology. Dr. Schabath has expertise in quantitative imaging (radiomics), molecular epidemiology, clinical epidemiology, and health disparities.

Dr. Segal is director of the Lung Microbiome Program, and an associate professor of medicine at NYU Grossman School of Medicine. He received his MD from Universidad Nacional de La Plata, Argentina, and his Master of Science from New York University. Dr. Segal is the principal investigator of multiple projects obtaining lower airway samples through research bronchoscopies as well as through clinically-indicated bronchoscopy. These projects include subjects with different pulmonary conditions wherein multiple culture-independent assays can be used to uncover bacteria presence in the lower airways and elucidate how they affect the host immune tone.

Jennifer Beane is an Assistant Professor at Boston University School of Medicine in the Section of Computational Biomedicine. Her research focuses on developing and applying computational methods to improve lung cancer risk stratification, early detection of lung cancer, and the development of new lung cancer chemoprevention strategies. She has contributed to research characterizing gene expression and cell population abundance changes in the airway field of injury associated with smoking and smoking cessation. She was involved in work leveraging the airway field of injury to develop a gene expression-based biomarker for the detection of lung cancer in patients undergoing bronchoscopy for suspicion of lung cancer. Research from her lab has also described alterations in lung squamous bronchial premalignant lesions and identified immune suppression mechanisms associated with lesion progression.

Dr. Bui is the Director of the Medical & Imaging Informatics (MII) Group at UCLA and holds the David Geffen Chair in Informatics.
Dr. Bui’s research includes informatics and data science for biomedical research and healthcare in areas related to distributed information architectures and mHealth; development, evaluation, and translation of AI-based methods (e.g., machine learning, reinforcement learning) for healthcare; and data visualization. His work bridges contemporary computational approaches with the opportunities arising from the breadth of biomedical observations and the electronic health record (EHR), tackling the associated translational challenges. In particular, his research looks to develop new ways to use both large-scale observational datasets and newer types of observations to improve aspects of cancer screening and diagnosis through more individually-tailored approaches.

TaCharra Woodard is an Acute Care Nurse Practitioner in Thoracic and Cardiovascular Surgery at the University of Texas M.D. Anderson Cancer Center in Houston, Texas. She has practiced with this division since 2013 and has worked in the organization since 2006. Ms. Woodard has predominantly served the oncologic population as a nurse practitioner since 2001. Ms. Woodard earned her Bachelor of Science in Nursing from Tennessee State University and Master's of Science in Nursing from Vanderbilt University. She has been a nurse for 25 years. Her areas of interest are Enhanced Recovery After Surgery and opioid stewardship postoperatively.